The official FDA list is pending publication as of this writing: Which Peptides are Coming Back BPC-157 Tissue repair, gut healing, tendon and ligament recovery, inflammation reduction Thymosin Alpha-1 (Ta1) Immune modulation, T-cell support approved in 30+ countries TB-500 (Thymosin Beta-4) Muscle repair, flexibility, accelerated injury recovery CJC-1295 / Ipamorelin Growth hormone support, sleep quality, lean muscle, metabolism AOD-9604 Fat metabolism support Selank / Semax Cognitive function, focus, stress resilience GHK-Cu (Copper Peptide) Wound healing, collagen production, skin regeneration MOTS-C Mitochondrial and metabolic regulation Five of the original 19 peptides are expected to remain restricted, most likely those with weaker safety data
Enhanced Skin Radiance: Works to reduce melanin production, combat hyperpigmentation, and brighten skin tone for a glowing complexion
It preserves cellular damage recovery, boosts collagen production, and maintains telomere length
GHK-Cu dosage in clinical and research contexts typically ranges from 0.5 to 3 mg administered monthly via subcutaneous injection, though individual protocols vary based on treatment goals and baseline health markers
This page provides an overview of those product details
While mitochondrial protein adducts are relevant to APAP hepatotoxicity since NAPQI binding to mitochondrial proteins correlates with the toxicity [35], the role of specific proteins targeted for adduct formation in the pathophysiology is not well understood
